Comparison of IVR and CATI Surveys in Bangladesh

NCT ID: NCT04508010

Last Updated: 2022-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

6151 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-08-25

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study focuses on mechanisms to adapt the performance of interactive voice response (IVR) and computer assisted telephone interviews (CATI) surveys conducted in low-and middle-income (LMIC) setting (Bangladesh) and evaluates how the two survey modalities (IVR and CATI) affect survey metrics, including response, completion and attrition rates.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using random digit dialing (RDD) sampling technique, participants will be randomized to one of two arms : 1) IVR or 2) CATI. Participants in the first study arm will receive an IVR survey. Participants in the second study arm will receive a CATI survey. Each questionnaire contains a set of demographic questions and one non-communicable disease (NCD) module (alcohol, or tobacco, or diet, or physical activity, or blood pressure and diabetes). We will examine contact, response, refusal and cooperation rates and demographic representativeness by each study arm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surveys and Questionnaires Non Communicable Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors
Data cleaning and analysis will be conducted by a statistician blinded to the study arm

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

IVR survey

Participants will receive an IVR survey

Group Type EXPERIMENTAL

IVR

Intervention Type OTHER

Participants will receive an IVR survey

CATI survey

Participants will receive a CATI survey

Group Type EXPERIMENTAL

CATI

Intervention Type OTHER

Participants will receive a CATI survey

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

IVR

Participants will receive an IVR survey

Intervention Type OTHER

CATI

Participants will receive a CATI survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Access to a mobile phone
* Greater or equal to 18 years of age
* In Bangladesh, conversant in Bengali language

Exclusion Criteria

* Less than 18 years of age
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institute of Epidemiology, Disease Control and Research

OTHER

Sponsor Role collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dustin Gibson, PhD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University Bloomberg School of Public Health

Iqbal Khan, PhD

Role: PRINCIPAL_INVESTIGATOR

Institute of Epidemiology, Disease Control and Research

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Epidemiology, Disease Control and Research

Dhaka, , Bangladesh

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Bangladesh

References

Explore related publications, articles, or registry entries linked to this study.

Pariyo GW, Greenleaf AR, Gibson DG, Ali J, Selig H, Labrique AB, Al Kibria GM, Khan IA, Masanja H, Flora MS, Ahmed S, Hyder AA. Does mobile phone survey method matter? Reliability of computer-assisted telephone interviews and interactive voice response non-communicable diseases risk factor surveys in low and middle income countries. PLoS One. 2019 Apr 10;14(4):e0214450. doi: 10.1371/journal.pone.0214450. eCollection 2019.

Reference Type BACKGROUND
PMID: 30969975 (View on PubMed)

Gibson DG, Wosu AC, Pariyo GW, Ahmed S, Ali J, Labrique AB, Khan IA, Rutebemberwa E, Flora MS, Hyder AA. Effect of airtime incentives on response and cooperation rates in non-communicable disease interactive voice response surveys: randomised controlled trials in Bangladesh and Uganda. BMJ Glob Health. 2019 Sep 6;4(5):e001604. doi: 10.1136/bmjgh-2019-001604. eCollection 2019.

Reference Type BACKGROUND
PMID: 31565406 (View on PubMed)

Gibson DG, Pereira A, Farrenkopf BA, Labrique AB, Pariyo GW, Hyder AA. Mobile Phone Surveys for Collecting Population-Level Estimates in Low- and Middle-Income Countries: A Literature Review. J Med Internet Res. 2017 May 5;19(5):e139. doi: 10.2196/jmir.7428.

Reference Type BACKGROUND
PMID: 28476725 (View on PubMed)

Hyder AA, Wosu AC, Gibson DG, Labrique AB, Ali J, Pariyo GW. Noncommunicable Disease Risk Factors and Mobile Phones: A Proposed Research Agenda. J Med Internet Res. 2017 May 5;19(5):e133. doi: 10.2196/jmir.7246.

Reference Type BACKGROUND
PMID: 28476722 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00007318 - Bangladesh

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

MOWI Qualitative Assessment
NCT03041831 COMPLETED
The Virtual BETTER Study
NCT05425797 COMPLETED NA